Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05241834
Title A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Medical Center Los Angeles California 90095 United States Details
University of California, San Francisco Medical Center San Francisco California 94158 United States Details
Emory University Atlanta Georgia 30322 United States Details
University of Chicago Medicine-Comprehensive Cancer Center Chicago Illinois 60637 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
Ohio State University Hospital Columbus Ohio 43210 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
Sarah Cannon Cancer Center Nashville Tennessee 37203 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field